Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBSERVATOIRE NATIONAL D'UTILISATION D'INFLECTRA™ EN VIE RÉELLE.

NCT02925338 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02925338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02925338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBSERVATOIRE NATIONAL D'UTILISATION D'INFLECTRA™ EN VIE RÉELLE.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 19, 2016
Completion date
April 12, 2021
Enrollment
1,431 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, crohn disease, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis